search
Back to results

Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy

Primary Purpose

Endometrial Diseases, Pain, Postoperative

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TENS 7000
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Endometrial Diseases focused on measuring endometrial biopsy, transcutaneous electrical nerve stimulation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • at least 18 years old
  • undergoing an outpatient endometrial biopsy
  • Duke gynecological oncology clinics and general gynecology clinic

Exclusion Criteria:

  • age younger than 18 years
  • unable to follow study instructions and/or independently adjust TENS settings
  • cutaneous damage at the TENS application site
  • pacemaker or automatic implanted cardiac defibrillator
  • inability to understand or declines to sign the informed consent form
  • previous personal experience using a TENS unit
  • pregnant women (will be excluded as part of standard of care for endometrial evaluation)

Sites / Locations

  • Duke University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Active TENS

Placebo TENS

Arm Description

Participants will be connected to a TENS 7000 that is turned on and working

Participants will be connected to a TENS 7000 however it will not be connected / will not be working

Outcomes

Primary Outcome Measures

Pain after Endometrial Biopsy, as measured by Visual Analogue Scale (VAS)
Scores are measured on a 100 mm VAS. The VAS ranges from 0 to 100 mm with the lower score indicating less pain and the higher score indicating greater pain

Secondary Outcome Measures

Number of participants who find the intervention acceptable based on survey response
A 0 to 100 mm scale similar to VAS to assess acceptability of TENS intervention
Number of participants who find the intervention tolerable based on survey response
A 0 to 100 mm scale similar to VAS to assess tolerability of TENS intervention
Change in Pain, as measured by Visual Analogue Scale (VAS) across different time intervals
Scores are measured on a 100 mm VAS. The VAS ranges from 0 to 100 mm with the lower score indicating less pain and the higher score indicating greater pain
Provider satisfaction with the procedure
A 0 to 100 mm scale similar to VAS to assess provider satisfaction

Full Information

First Posted
July 22, 2022
Last Updated
December 19, 2022
Sponsor
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT05472740
Brief Title
Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy
Official Title
Transcutaneous Electrical Nerve Stimulation for Analgesia During Outpatient Endometrial Biopsy: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 13, 2022 (Actual)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
January 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to see whether transcutaneous electrical nerve stimulation (or TENS) reduces pain during an endometrial biopsy. A TENS unit is an over-the-counter, FDA approved device that sends low-level electrical impulses through the skin to reduce the amount of discomfort experienced during procedures. A TENS unit is very low-risk and used in a lot of ways, including for chronic pain, after surgery, and during labor. Since there is no standard way of managing discomfort during an endometrial biopsy, the investigators think that TENS might be helpful. Participating in the study may require some additional time in clinic to answer research-related questions. Subjects will be asked to answer demographic questions (which will be combined anonymously) before and after the procedure, as well as rate subject's pain at different time points during the procedure. The biggest benefit in participating is that subject's discomfort might be lower during and after the procedure. Subjects may not benefit from participating in this study. There is a small risk of a skin reaction from wearing the TENS pads.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endometrial Diseases, Pain, Postoperative
Keywords
endometrial biopsy, transcutaneous electrical nerve stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Masking Description
The participant and the provider completing the endometrial biopsy will be blinded to what group (intervention or placebo) that the subject is in. The clinical research coordinator assisting with the study and placement of the TENS will not be blinded.
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active TENS
Arm Type
Experimental
Arm Description
Participants will be connected to a TENS 7000 that is turned on and working
Arm Title
Placebo TENS
Arm Type
Placebo Comparator
Arm Description
Participants will be connected to a TENS 7000 however it will not be connected / will not be working
Intervention Type
Device
Intervention Name(s)
TENS 7000
Intervention Description
TENS device to be used in both the active and placebo groups
Primary Outcome Measure Information:
Title
Pain after Endometrial Biopsy, as measured by Visual Analogue Scale (VAS)
Description
Scores are measured on a 100 mm VAS. The VAS ranges from 0 to 100 mm with the lower score indicating less pain and the higher score indicating greater pain
Time Frame
Immediately after endometrial biopsy
Secondary Outcome Measure Information:
Title
Number of participants who find the intervention acceptable based on survey response
Description
A 0 to 100 mm scale similar to VAS to assess acceptability of TENS intervention
Time Frame
End of procedure
Title
Number of participants who find the intervention tolerable based on survey response
Description
A 0 to 100 mm scale similar to VAS to assess tolerability of TENS intervention
Time Frame
End of procedure
Title
Change in Pain, as measured by Visual Analogue Scale (VAS) across different time intervals
Description
Scores are measured on a 100 mm VAS. The VAS ranges from 0 to 100 mm with the lower score indicating less pain and the higher score indicating greater pain
Time Frame
Speculum placement, tenaculum placement, 5 minutes after biopsy, and 15 minutes after biopsy
Title
Provider satisfaction with the procedure
Description
A 0 to 100 mm scale similar to VAS to assess provider satisfaction
Time Frame
End of procedure

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: at least 18 years old undergoing an outpatient endometrial biopsy Duke gynecological oncology clinics and general gynecology clinic Exclusion Criteria: age younger than 18 years unable to follow study instructions and/or independently adjust TENS settings cutaneous damage at the TENS application site pacemaker or automatic implanted cardiac defibrillator inability to understand or declines to sign the informed consent form previous personal experience using a TENS unit pregnant women (will be excluded as part of standard of care for endometrial evaluation)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Amelia Scott
Phone
919-684-9065
Email
amelia.lorenzo@duke.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura Havrilesky, MD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27705
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amelia Scott
Phone
919-684-9065
Email
amelia.lorenzo@duke.edu

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34352845
Citation
Lerma K, Goldthwaite LM, Blumenthal PD, Shaw KA. Transcutaneous Electrical Nerve Stimulation for Pain Management of Aspiration Abortion up to 83 Days of Gestation: A Randomized Controlled Trial. Obstet Gynecol. 2021 Sep 1;138(3):417-425. doi: 10.1097/AOG.0000000000004502.
Results Reference
background
PubMed Identifier
22009510
Citation
Yilmazer M, Kose S, Arioz DT, Koken G, Ozbulut O. Efficacy of transcutaneous electrical nerve stimulation for pain relief in women undergoing office endometrial biopsy. Arch Gynecol Obstet. 2012 Apr;285(4):1059-64. doi: 10.1007/s00404-011-2111-7. Epub 2011 Oct 19.
Results Reference
background
PubMed Identifier
28079781
Citation
Lison JF, Amer-Cuenca JJ, Piquer-Marti S, Benavent-Caballer V, Bivia-Roig G, Marin-Buck A. Transcutaneous Nerve Stimulation for Pain Relief During Office Hysteroscopy: A Randomized Controlled Trial. Obstet Gynecol. 2017 Feb;129(2):363-370. doi: 10.1097/AOG.0000000000001842.
Results Reference
background

Learn more about this trial

Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy

We'll reach out to this number within 24 hrs